Literature DB >> 15652656

Octreotide ameliorates sepsis-induced pelvic inflammation in female rats by a neutrophil-dependent mechanism.

Göksel Sener1, Sule Cetinel, Gözde Erkanli, Nursal Gedik, Berrak C Yeğen.   

Abstract

Sepsis is a generalized inflammatory response, which involves organ systems remote from the locus of the initial infectious insult, accompanied by the release of cytokines and the subsequent formation of reactive oxygen and nitrogen species. The aim of this study was to investigate the possible protective effect of octreotide (OCT), a synthetic somatostatin analogue, against sepsis-induced oxidative damage in the uterine and ovarian tissues of rats. Sepsis was induced by caecal ligation and puncture method in female Wistar albino rats. Sepsis and sham operated (control) groups received either saline or OCT (50 microg/kg, i.p.; Novartis) immediately after the operation and at 12 h. Twenty-four hours after the surgery, rats were decapitated and serum TNF-alpha levels and tissue malondialdehyde (MDA) content, glutathione (GSH) levels and myeloperoxidase (MPO) activity were determined in the uterus and ovaries. Oxidant-induced tissue fibrosis was determined by tissue collagen contents, while the extent of tissue injuries was analyzed microscopically. Sepsis increased serum TNF-alpha levels and resulted in decreased GSH levels and increased MDA levels, MPO activity and collagen contents in both the uterus and the ovaries (p<0.05-0.001) indicating the presence of the oxidative damage, as also confirmed by histological analysis. On the other hand, OCT administration reversed these oxidant responses and reduced the severity of microscopic damage (p<0.001). In conclusion, OCT protects against sepsis-induced oxidative injury of the uterine and ovarian tissues by diminishing neutrophil infiltration, an important source of oxygen free radicals. Our results suggest that OCT may be of therapeutic value in ameliorating sepsis-associated pelvic inflammation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652656     DOI: 10.1016/j.peptides.2004.10.013

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

Review 1.  Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.

Authors:  Erika Pintér; Gábor Pozsgai; Zsófia Hajna; Zsuzsanna Helyes; János Szolcsányi
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

2.  Impaired defense mechanism against inflammation, hyperalgesia, and airway hyperreactivity in somatostatin 4 receptor gene-deleted mice.

Authors:  Zsuzsanna Helyes; Erika Pintér; Katalin Sándor; Krisztián Elekes; Agnes Bánvölgyi; Dániel Keszthelyi; Eva Szoke; Dániel M Tóth; Zoltán Sándor; László Kereskai; Gábor Pozsgai; Jeremy P Allen; Piers C Emson; Adrienn Markovics; János Szolcsányi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-21       Impact factor: 11.205

3.  Octreotide Protects the Mouse Retina against Ischemic Reperfusion Injury through Regulation of Antioxidation and Activation of NF-κB.

Authors:  Jun Wang; Ziqiang Sun; Junsheng Shen; Dongdong Wu; Fang Liu; Ruisheng Yang; Shaoping Ji; Ailing Ji; Yanzhang Li
Journal:  Oxid Med Cell Longev       Date:  2015-06-14       Impact factor: 6.543

4.  Octreotide activates autophagy to alleviate lipopolysaccharide-induced human pulmonary epithelial cell injury by inhibiting the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling pathway.

Authors:  Sumian Zhang; Cijun Tang; Xuebin Wang
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

5.  Inhibition of infection-mediated preterm birth by administration of broad spectrum chemokine inhibitor in mice.

Authors:  Oksana Shynlova; Anna Dorogin; Yunqing Li; Stephen Lye
Journal:  J Cell Mol Med       Date:  2014-06-04       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.